Authors: Zhao, SZ Reynolds, MW Lefkowith, J Whelton, A Arellano, FM

Citation: Sz. Zhao et al., A comparison of renal-related adverse drug reactions between rofecoxib andcelecoxib, based on the World Health Organization Uppsala Monitoring Centre safety database, CLIN THER, 23(9), 2001, pp. 1478-1491

Authors: White, WB Whelton, A

Citation: Wb. White et A. Whelton, Cardiovascular events and COX-2 inhibitors, J AM MED A, 286(22), 2001, pp. 2811-2811

Authors: Whelton, A

Citation: A. Whelton, Cyclooxygenase-2 inhibition and renal function, ANN INT MED, 134(11), 2001, pp. 1077-1078

Authors: Silverstein, FE Faich, G Goldstein, JL Simon, LS Pincus, T Whelton, A Makuch, R Eisen, G Agarwal, NM Stenson, WF Burr, AM Zhao, WW Kent, JD Lefkowith, JB Verburg, KM Geis, GS

Citation: Fe. Silverstein et al., Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatorydrugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial, J AM MED A, 284(10), 2000, pp. 1247-1255

Authors: Schiff, MH Whelton, A

Citation: Mh. Schiff et A. Whelton, Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis, SEM ARTH RH, 30(3), 2000, pp. 196-208

Authors: Whelton, A Schulman, G Wallemark, C Drower, EJ Isakson, PC Verburg, KM Geis, GS

Citation: A. Whelton et al., Effects of celecoxib and naproxen on renal function in the elderly, ARCH IN MED, 160(10), 2000, pp. 1465-1470